메뉴 건너뛰기




Volumn 7, Issue 1, 2015, Pages

Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas

Author keywords

5 hydroxymethylcytosine; DNA demethylation; Epigenetics; Isocitrate dehydrogenase 2 (IDH2); MECOM (MDS1 and EV1 complex locus); Melanoma; MLL2; Next generation sequencing (NGS); Ten eleven translocation (TET)

Indexed keywords

B RAF KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; ISOCITRATE DEHYDROGENASE 1; NEUROFIBROMIN; PROTEIN P53;

EID: 84938414877     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/s13148-015-0091-3     Document Type: Article
Times cited : (46)

References (66)
  • 1
    • 84905159649 scopus 로고    scopus 로고
    • Skin Cancer
    • Stewart BW, Wild CP, (eds), International Agency for Research on Cancer, Lyon, France
    • Lian CG, Mihm MC, Pierard G, Tommasino M. Skin Cancer. In: Stewart BW, Wild CP, editors. World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer; 2014.
    • (2014) World Cancer Report 2014
    • Lian, C.G.1    Mihm, M.C.2    Pierard, G.3    Tommasino, M.4
  • 2
    • 18444374405 scopus 로고    scopus 로고
    • Mutations of the BRAF gene in human cancer
    • COI: 1:CAS:528:DC%2BD38XkvVagsLo%3D, PID: 12068308
    • Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–54.
    • (2002) Nature. , vol.417 , pp. 949-954
    • Davies, H.1    Bignell, G.R.2    Cox, C.3    Stephens, P.4    Edkins, S.5    Clegg, S.6
  • 3
    • 79959795786 scopus 로고    scopus 로고
    • Improved survival with vemurafenib in melanoma with BRAF V600E mutation
    • COI: 1:CAS:528:DC%2BC3MXosVeitbs%3D, PID: 21639808
    • Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364:2507–16.
    • (2011) N Engl J Med , vol.364 , pp. 2507-2516
    • Chapman, P.B.1    Hauschild, A.2    Robert, C.3    Haanen, J.B.4    Ascierto, P.5    Larkin, J.6
  • 5
    • 84938429089 scopus 로고    scopus 로고
    • Chapter 118: molecular biology of cutaneous melanoma
    • Devita VT, Lawrence TS, Rosenberg SA, (eds), Lippincott Williams & Wilkins, Philadelphia, PA
    • Garraway LA, Chin L. Chapter 118: molecular biology of cutaneous melanoma. In: Devita Jr VT, Lawrence TS, Rosenberg SA, editors. Cancer: Principles & Practice of Oncology, 9e. Philadelphia, PA: Lippincott Williams & Wilkins; 2011.
    • (2011) Cancer: Principles & Practice of Oncology, 9e
    • Garraway, L.A.1    Chin, L.2
  • 6
    • 84919445438 scopus 로고    scopus 로고
    • Deciphering root causes of intrinsic BRAF inhibitor resistance in melanoma: ushering in a new genomics case reports feature for Annals of Oncology
    • COI: 1:STN:280:DC%2BC2cvotVaqug%3D%3D, PID: 24569915
    • Swanton C, Andre F, Mardis E. Deciphering root causes of intrinsic BRAF inhibitor resistance in melanoma: ushering in a new genomics case reports feature for Annals of Oncology. Ann Oncol. 2014;25:917–8.
    • (2014) Ann Oncol. , vol.25 , pp. 917-918
    • Swanton, C.1    Andre, F.2    Mardis, E.3
  • 7
    • 84912065268 scopus 로고    scopus 로고
    • Combination of RAF and MEK inhibition for the treatment of BRAF-mutated melanoma: feedback is not encouraged
    • COI: 1:CAS:528:DC%2BC2cXhvFSmt7vM, PID: 25517746
    • Chapman PB, Solit DB, Rosen N. Combination of RAF and MEK inhibition for the treatment of BRAF-mutated melanoma: feedback is not encouraged. Cancer Cell. 2014;26:603–4.
    • (2014) Cancer Cell. , vol.26 , pp. 603-604
    • Chapman, P.B.1    Solit, D.B.2    Rosen, N.3
  • 8
    • 84868224906 scopus 로고    scopus 로고
    • Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
    • COI: 1:CAS:528:DC%2BC38Xhs1eksLrJ, PID: 23020132
    • Flaherty KT, Infante JR, Daud A, Gonzalez R, Kefford RF, Sosman J, et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med. 2012;367:1694–703.
    • (2012) N Engl J Med. , vol.367 , pp. 1694-1703
    • Flaherty, K.T.1    Infante, J.R.2    Daud, A.3    Gonzalez, R.4    Kefford, R.F.5    Sosman, J.6
  • 9
    • 84863673204 scopus 로고    scopus 로고
    • Improved survival with MEK inhibition in BRAF-mutated melanoma
    • COI: 1:CAS:528:DC%2BC38XhtFKjs7zN, PID: 22663011
    • Flaherty KT, Robert C, Hersey P, Nathan P, Garbe C, Milhem M, et al. Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med. 2012;367:107–14.
    • (2012) N Engl J Med , vol.367 , pp. 107-114
    • Flaherty, K.T.1    Robert, C.2    Hersey, P.3    Nathan, P.4    Garbe, C.5    Milhem, M.6
  • 10
    • 77954801079 scopus 로고    scopus 로고
    • Improved survival with ipilimumab in patients with metastatic melanoma
    • COI: 1:CAS:528:DC%2BC3cXhtVCrtrbN, PID: 20525992
    • Hodi FS, O’day SJ, Mcdermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711–23.
    • (2010) N Engl J Med , vol.363 , pp. 711-723
    • Hodi, F.S.1    O’day, S.J.2    Mcdermott, D.F.3    Weber, R.W.4    Sosman, J.A.5    Haanen, J.B.6
  • 11
    • 84925222119 scopus 로고    scopus 로고
    • Nivolumab in previously untreated melanoma without BRAF mutation
    • COI: 1:CAS:528:DC%2BC2MXisFGqsLg%3D, PID: 25399552
    • Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med. 2015;372:320–30.
    • (2015) N Engl J Med. , vol.372 , pp. 320-330
    • Robert, C.1    Long, G.V.2    Brady, B.3    Dutriaux, C.4    Maio, M.5    Mortier, L.6
  • 12
    • 84905196758 scopus 로고    scopus 로고
    • Melanoma epigenetics: novel mechanisms, markers, and medicines
    • COI: 1:CAS:528:DC%2BC2cXhtVKls7vM, PID: 24978641
    • Lee JJ, Murphy GF, Lian CG. Melanoma epigenetics: novel mechanisms, markers, and medicines. Lab Invest. 2014;94:822–38.
    • (2014) Lab Invest. , vol.94 , pp. 822-838
    • Lee, J.J.1    Murphy, G.F.2    Lian, C.G.3
  • 13
    • 84866419591 scopus 로고    scopus 로고
    • Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma
    • COI: 1:CAS:528:DC%2BC38XhtlKrsr%2FI, PID: 22980977
    • Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell. 2012;150:1135–46.
    • (2012) Cell. , vol.150 , pp. 1135-1146
    • Lian, C.G.1    Xu, Y.2    Ceol, C.3    Wu, F.4    Larson, A.5    Dresser, K.6
  • 14
    • 84928572472 scopus 로고    scopus 로고
    • The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
    • COI: 1:CAS:528:DC%2BC2MXhtF2lu7rO, PID: 25609585
    • Zingg D, Debbache J, Schaefer SM, Tuncer E, Frommel SC, Cheng P, et al. The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors. Nat Commun. 2015;6:6051.
    • (2015) Nat Commun. , vol.6 , pp. 6051
    • Zingg, D.1    Debbache, J.2    Schaefer, S.M.3    Tuncer, E.4    Frommel, S.C.5    Cheng, P.6
  • 15
    • 84908321120 scopus 로고    scopus 로고
    • PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies
    • PID: 25119042
    • De Raedt T, Beert E, Pasmant E, Luscan A, Brems H, Ortonne N, et al. PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies. Nature. 2014;514:247–51.
    • (2014) Nature. , vol.514 , pp. 247-251
    • De Raedt, T.1    Beert, E.2    Pasmant, E.3    Luscan, A.4    Brems, H.5    Ortonne, N.6
  • 16
    • 84877590959 scopus 로고    scopus 로고
    • MAP kinase signaling and inhibition in melanoma
    • COI: 1:CAS:528:DC%2BC38Xht12jt7jL, PID: 22945644
    • Sullivan RJ, Flaherty K. MAP kinase signaling and inhibition in melanoma. Oncogene. 2013;32:2373–9.
    • (2013) Oncogene. , vol.32 , pp. 2373-2379
    • Sullivan, R.J.1    Flaherty, K.2
  • 17
    • 84904729930 scopus 로고    scopus 로고
    • Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition
    • COI: 1:STN:280:DC%2BC2cvivVaisQ%3D%3D, PID: 24504448
    • Turajlic S, Furney SJ, Stamp G, Rana S, Ricken G, Oduko Y, et al. Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition. Ann Oncol. 2014;25:959–67.
    • (2014) Ann Oncol. , vol.25 , pp. 959-967
    • Turajlic, S.1    Furney, S.J.2    Stamp, G.3    Rana, S.4    Ricken, G.5    Oduko, Y.6
  • 18
    • 84885022736 scopus 로고    scopus 로고
    • The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma
    • COI: 1:CAS:528:DC%2BC3sXhsVWru7bE, PID: 23982524
    • Kaufman HL, Kirkwood JM, Hodi FS, Agarwala S, Amatruda T, Bines SD, et al. The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma. Nat Rev Clin Oncol. 2013;10:588–98.
    • (2013) Nat Rev Clin Oncol. , vol.10 , pp. 588-598
    • Kaufman, H.L.1    Kirkwood, J.M.2    Hodi, F.S.3    Agarwala, S.4    Amatruda, T.5    Bines, S.D.6
  • 22
    • 84875740314 scopus 로고    scopus 로고
    • Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal
    • PID: 23550210
    • Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.
    • (2013) Sci Signal , vol.6 , pp. pl1
    • Gao, J.1    Aksoy, B.A.2    Dogrusoz, U.3    Dresdner, G.4    Gross, B.5    Sumer, S.O.6
  • 23
    • 84866002291 scopus 로고    scopus 로고
    • The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data
    • PID: 22588877
    • Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401–4.
    • (2012) Cancer Discov. , vol.2 , pp. 401-404
    • Cerami, E.1    Gao, J.2    Dogrusoz, U.3    Gross, B.E.4    Sumer, S.O.5    Aksoy, B.A.6
  • 26
    • 84874189784 scopus 로고    scopus 로고
    • Highly recurrent TERT promoter mutations in human melanoma
    • COI: 1:CAS:528:DC%2BC3sXis1Oisbo%3D, PID: 23348506
    • Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science. 2013;339:957–9.
    • (2013) Science. , vol.339 , pp. 957-959
    • Huang, F.W.1    Hodis, E.2    Xu, M.J.3    Kryukov, G.V.4    Chin, L.5    Garraway, L.A.6
  • 27
    • 84899648964 scopus 로고    scopus 로고
    • Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma
    • COI: 1:CAS:528:DC%2BC2cXltFOlsL8%3D, PID: 24686846
    • Shi J, Yang XR, Ballew B, Rotunno M, Calista D, Fargnoli MC, et al. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nat Genet. 2014;46:482–6.
    • (2014) Nat Genet. , vol.46 , pp. 482-486
    • Shi, J.1    Yang, X.R.2    Ballew, B.3    Rotunno, M.4    Calista, D.5    Fargnoli, M.C.6
  • 28
    • 0037096962 scopus 로고    scopus 로고
    • A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families
    • PID: 12115352
    • Tucker MA, Fraser MC, Goldstein AM, Struewing JP, King MA, Crawford JT, et al. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Cancer. 2002;94:3192–209.
    • (2002) Cancer. , vol.94 , pp. 3192-3209
    • Tucker, M.A.1    Fraser, M.C.2    Goldstein, A.M.3    Struewing, J.P.4    King, M.A.5    Crawford, J.T.6
  • 29
    • 84902536316 scopus 로고    scopus 로고
    • Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma
    • COI: 1:CAS:528:DC%2BC2cXhtVSqs7%2FM, PID: 24628946
    • Jeck WR, Parker J, Carson CC, Shields JM, Sambade MJ, Peters EC, et al. Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma. Pigment Cell Melanoma Res. 2014;27:653–63.
    • (2014) Pigment Cell Melanoma Res. , vol.27 , pp. 653-663
    • Jeck, W.R.1    Parker, J.2    Carson, C.C.3    Shields, J.M.4    Sambade, M.J.5    Peters, E.C.6
  • 30
    • 3843084078 scopus 로고    scopus 로고
    • The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website
    • COI: 1:CAS:528:DC%2BD2cXls1ehsbo%3D, PID: 15188009
    • Bamford S, Dawson E, Forbes S, Clements J, Pettett R, Dogan A, et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer. 2004;91:355–8.
    • (2004) Br J Cancer. , vol.91 , pp. 355-358
    • Bamford, S.1    Dawson, E.2    Forbes, S.3    Clements, J.4    Pettett, R.5    Dogan, A.6
  • 31
    • 84911941605 scopus 로고    scopus 로고
    • Clonal architectures and driver mutations in metastatic melanomas
    • PID: 25393105
    • Ding L, Kim M, Kanchi KL, Dees ND, Lu C, Griffith M, et al. Clonal architectures and driver mutations in metastatic melanomas. PLoS One. 2014;9:e111153.
    • (2014) PLoS One. , vol.9 , pp. e111153
    • Ding, L.1    Kim, M.2    Kanchi, K.L.3    Dees, N.D.4    Lu, C.5    Griffith, M.6
  • 32
    • 33747332544 scopus 로고    scopus 로고
    • Malignant melanoma: genetics and therapeutics in the genomic era
    • COI: 1:CAS:528:DC%2BD28XoslWqu74%3D, PID: 16912270
    • Chin L, Garraway LA, Fisher DE. Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev. 2006;20:2149–82.
    • (2006) Genes Dev. , vol.20 , pp. 2149-2182
    • Chin, L.1    Garraway, L.A.2    Fisher, D.E.3
  • 33
    • 42949122111 scopus 로고    scopus 로고
    • High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated
    • COI: 1:CAS:528:DC%2BD1cXkvFeisbc%3D, PID: 18272813
    • Lugthart S, Van Drunen E, Van Norden Y, Van Hoven A, Erpelinck CA, Valk PJ, et al. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Blood. 2008;111:4329–37.
    • (2008) Blood. , vol.111 , pp. 4329-4337
    • Lugthart, S.1    Van Drunen, E.2    Van Norden, Y.3    Van Hoven, A.4    Erpelinck, C.A.5    Valk, P.J.6
  • 34
    • 84871820815 scopus 로고    scopus 로고
    • Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group
    • PID: 23008312
    • Groschel S, Schlenk RF, Engelmann J, Rockova V, Teleanu V, Kuhn MW, et al. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group. J Clin Oncol. 2013;31:95–103.
    • (2013) J Clin Oncol. , vol.31 , pp. 95-103
    • Groschel, S.1    Schlenk, R.F.2    Engelmann, J.3    Rockova, V.4    Teleanu, V.5    Kuhn, M.W.6
  • 35
    • 84881086684 scopus 로고    scopus 로고
    • EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation
    • COI: 1:CAS:528:DC%2BC3sXht12htbrJ, PID: 23858473
    • Bard-chapeau EA, Gunaratne J, Kumar P, Chua BQ, Muller J, Bard FA, et al. EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation. Proc Natl Acad Sci U S A. 2013;110:E2885–94.
    • (2013) Proc Natl Acad Sci U S A. , vol.110 , pp. E2885-E2894
    • Bard-chapeau, E.A.1    Gunaratne, J.2    Kumar, P.3    Chua, B.Q.4    Muller, J.5    Bard, F.A.6
  • 36
    • 84864315640 scopus 로고    scopus 로고
    • Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis
    • COI: 1:CAS:528:DC%2BC38XhtV2isbjO, PID: 22494115
    • Kataoka K, Kurokawa M. Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis. Cancer Sci. 2012;103:1371–7.
    • (2012) Cancer Sci. , vol.103 , pp. 1371-1377
    • Kataoka, K.1    Kurokawa, M.2
  • 37
    • 84874016584 scopus 로고    scopus 로고
    • EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells
    • COI: 1:CAS:528:DC%2BC3sXjsVSjs7s%3D, PID: 23457546
    • Rommer A, Steinmetz B, Herbst F, Hackl H, Heffeter P, Heilos D, et al. EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells. PLoS One. 2013;8:e56308.
    • (2013) PLoS One. , vol.8 , pp. e56308
    • Rommer, A.1    Steinmetz, B.2    Herbst, F.3    Hackl, H.4    Heffeter, P.5    Heilos, D.6
  • 38
    • 33846019277 scopus 로고    scopus 로고
    • Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark
    • COI: 1:CAS:528:DC%2BD2sXhtFSntbk%3D, PID: 17218268
    • Ruthenburg AJ, Allis CD, Wysocka J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell. 2007;25:15–30.
    • (2007) Mol Cell. , vol.25 , pp. 15-30
    • Ruthenburg, A.J.1    Allis, C.D.2    Wysocka, J.3
  • 39
    • 84867908690 scopus 로고    scopus 로고
    • Global identification of MLL2-targeted loci reveals MLL2’s role in diverse signaling pathways
    • COI: 1:CAS:528:DC%2BC38XhvVSltLnP, PID: 23045699
    • Guo C, Chang CC, Wortham M, Chen LH, Kernagis DN, Qin X, et al. Global identification of MLL2-targeted loci reveals MLL2’s role in diverse signaling pathways. Proc Natl Acad Sci U S A. 2012;109:17603–8.
    • (2012) Proc Natl Acad Sci U S A. , vol.109 , pp. 17603-17608
    • Guo, C.1    Chang, C.C.2    Wortham, M.3    Chen, L.H.4    Kernagis, D.N.5    Qin, X.6
  • 40
    • 84922068082 scopus 로고    scopus 로고
    • Genetic landscape of esophageal squamous cell carcinoma
    • COI: 1:CAS:528:DC%2BC2cXhsVSqtLnF, PID: 25151357
    • Gao YB, Chen ZL, Li JG, Hu XD, Shi XJ, Sun ZM, et al. Genetic landscape of esophageal squamous cell carcinoma. Nat Genet. 2014;46:1097–102.
    • (2014) Nat Genet. , vol.46 , pp. 1097-1102
    • Gao, Y.B.1    Chen, Z.L.2    Li, J.G.3    Hu, X.D.4    Shi, X.J.5    Sun, Z.M.6
  • 41
    • 84905963343 scopus 로고    scopus 로고
    • Exome sequencing identifies frequent mutation of MLL2 in non-small cell lung carcinoma from Chinese patients
    • COI: 1:CAS:528:DC%2BC2MXktlOhsb0%3D, PID: 25112956
    • Yin S, Yang J, Lin B, Deng W, Zhang Y, Yi X, et al. Exome sequencing identifies frequent mutation of MLL2 in non-small cell lung carcinoma from Chinese patients. Sci Rep. 2014;4:6036.
    • (2014) Sci Rep. , vol.4 , pp. 6036
    • Yin, S.1    Yang, J.2    Lin, B.3    Deng, W.4    Zhang, Y.5    Yi, X.6
  • 42
    • 84906818599 scopus 로고    scopus 로고
    • Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer
    • COI: 1:CAS:528:DC%2BC2cXitVWqsrfE, PID: 24978188
    • Ross JS, Wang K, Elkadi OR, Tarasen A, Foulke L, Sheehan CE, et al. Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer. J Clin Pathol. 2014;67:772–6.
    • (2014) J Clin Pathol. , vol.67 , pp. 772-776
    • Ross, J.S.1    Wang, K.2    Elkadi, O.R.3    Tarasen, A.4    Foulke, L.5    Sheehan, C.E.6
  • 44
    • 84876889621 scopus 로고    scopus 로고
    • What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
    • COI: 1:CAS:528:DC%2BC3sXnsl2gtro%3D, PID: 23630074
    • Losman JA, Kaelin Jr WG. What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev. 2013;27:836–52.
    • (2013) Genes Dev. , vol.27 , pp. 836-852
    • Losman, J.A.1    Kaelin, W.G.2
  • 45
    • 77954697566 scopus 로고    scopus 로고
    • Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism
    • COI: 1:CAS:528:DC%2BC3cXptlegs7c%3D, PID: 20513808
    • Reitman ZJ, Yan H. Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. J Natl Cancer Inst. 2010;102:932–41.
    • (2010) J Natl Cancer Inst. , vol.102 , pp. 932-941
    • Reitman, Z.J.1    Yan, H.2
  • 46
    • 80052495940 scopus 로고    scopus 로고
    • Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA
    • COI: 1:CAS:528:DC%2BC3MXhtV2jt7nO, PID: 21817016
    • He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science. 2011;333:1303–7.
    • (2011) Science. , vol.333 , pp. 1303-1307
    • He, Y.F.1    Li, B.Z.2    Li, Z.3    Liu, P.4    Wang, Y.5    Tang, Q.6
  • 47
    • 80052461558 scopus 로고    scopus 로고
    • Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
    • COI: 1:CAS:528:DC%2BC3MXhtV2jt7nN, PID: 21778364
    • Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2011;333:1300–3.
    • (2011) Science. , vol.333 , pp. 1300-1303
    • Ito, S.1    Shen, L.2    Dai, Q.3    Wu, S.C.4    Collins, L.B.5    Swenberg, J.A.6
  • 48
    • 80052476744 scopus 로고    scopus 로고
    • Molecular biology. Demystifying DNA demethylation
    • COI: 1:CAS:528:DC%2BC3MXht1Cls7nF, PID: 21885763
    • Nabel CS, Kohli RM. Molecular biology. Demystifying DNA demethylation. Science. 2011;333:1229–30.
    • (2011) Science , vol.333 , pp. 1229-1230
    • Nabel, C.S.1    Kohli, R.M.2
  • 49
    • 84555189745 scopus 로고    scopus 로고
    • DNA methylation: TET proteins—guardians of CpG islands?
    • COI: 1:CAS:528:DC%2BC3MXhs1OltbbI
    • Williams K, Christensen J, Helin K. DNA methylation: TET proteins—guardians of CpG islands? EMBOR Rep. 2012;13:28–35.
    • (2012) EMBOR Rep. , vol.13 , pp. 28-35
    • Williams, K.1    Christensen, J.2    Helin, K.3
  • 50
    • 84861665776 scopus 로고    scopus 로고
    • 5-Methylcytosine and 5-hydroxymethylcytosine spatiotemporal profiles in the mouse zygote
    • COI: 1:CAS:528:DC%2BC38XotlCqsrc%3D, PID: 22693592
    • Salvaing J, Aguirre-Lavin T, Boulesteix C, Lehmann G, Debey P, Beaujean N. 5-Methylcytosine and 5-hydroxymethylcytosine spatiotemporal profiles in the mouse zygote. PLoS One. 2012;7:e38156.
    • (2012) PLoS One. , vol.7 , pp. e38156
    • Salvaing, J.1    Aguirre-Lavin, T.2    Boulesteix, C.3    Lehmann, G.4    Debey, P.5    Beaujean, N.6
  • 51
    • 84856058152 scopus 로고    scopus 로고
    • Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers
    • PID: 21896958
    • Haffner MC, Chaux A, Meeker AK, Esopi DM, Gerber J, Pellakuru LG, et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget. 2011;2:627–37.
    • (2011) Oncotarget. , vol.2 , pp. 627-637
    • Haffner, M.C.1    Chaux, A.2    Meeker, A.K.3    Esopi, D.M.4    Gerber, J.5    Pellakuru, L.G.6
  • 52
    • 84891659302 scopus 로고    scopus 로고
    • 5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi
    • COI: 1:CAS:528:DC%2BC3sXhslaisbfK, PID: 24169492
    • Uchiyama R, Uhara H, Uchiyama A, Ogawa E, Takazawa Y, Ashida A, et al. 5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi. J Dermatol Sci. 2014;73:161–3.
    • (2014) J Dermatol Sci. , vol.73 , pp. 161-163
    • Uchiyama, R.1    Uhara, H.2    Uchiyama, A.3    Ogawa, E.4    Takazawa, Y.5    Ashida, A.6
  • 53
    • 84922019757 scopus 로고    scopus 로고
    • 5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies
    • COI: 1:CAS:528:DC%2BC2MXjvFWrt74%3D, PID: 25081754
    • Lee JJ, Granter SR, Laga AC, Saavedra AP, Zhan Q, Guo W, et al. 5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies. Mod Pathol. 2015;28:218–29.
    • (2015) Mod Pathol. , vol.28 , pp. 218-229
    • Lee, J.J.1    Granter, S.R.2    Laga, A.C.3    Saavedra, A.P.4    Zhan, Q.5    Guo, W.6
  • 54
    • 84898547095 scopus 로고    scopus 로고
    • Driver mutations of cancer epigenomes
    • COI: 1:CAS:528:DC%2BC2cXks1Olt7s%3D, PID: 24622842
    • Roy DM, Walsh LA, Chan TA. Driver mutations of cancer epigenomes. Protein Cell. 2014;5:265–96.
    • (2014) Protein Cell. , vol.5 , pp. 265-296
    • Roy, D.M.1    Walsh, L.A.2    Chan, T.A.3
  • 55
    • 84906833959 scopus 로고    scopus 로고
    • Identification of a melanoma susceptibility locus and somatic mutation in TET2
    • COI: 1:CAS:528:DC%2BC2cXhslehs7bM, PID: 24980573
    • Song F, Amos CI, Lee JE, Lian CG, Fang S, Liu H, et al. Identification of a melanoma susceptibility locus and somatic mutation in TET2. Carcinogenesis. 2014;35:2097–101.
    • (2014) Carcinogenesis. , vol.35 , pp. 2097-2101
    • Song, F.1    Amos, C.I.2    Lee, J.E.3    Lian, C.G.4    Fang, S.5    Liu, H.6
  • 56
    • 78049248595 scopus 로고    scopus 로고
    • Lighting a path to pigmentation: mechanisms of MITF induction by UV
    • PID: 20973930
    • Liu JJ, Fisher DE. Lighting a path to pigmentation: mechanisms of MITF induction by UV. Pigment Cell Melanoma Res. 2010;23:741–5.
    • (2010) Pigment Cell Melanoma Res. , vol.23 , pp. 741-745
    • Liu, J.J.1    Fisher, D.E.2
  • 57
    • 52149115782 scopus 로고    scopus 로고
    • UV and pigmentation: molecular mechanisms and social controversies
    • COI: 1:CAS:528:DC%2BD1cXht1Kqt7zK, PID: 18821855
    • Tran TT, Schulman J, Fisher DE. UV and pigmentation: molecular mechanisms and social controversies. Pigment Cell Melanoma Res. 2008;21:509–16.
    • (2008) Pigment Cell Melanoma Res. , vol.21 , pp. 509-516
    • Tran, T.T.1    Schulman, J.2    Fisher, D.E.3
  • 58
    • 84899512224 scopus 로고    scopus 로고
    • Environmental exposures, epigenetic changes and the risk of lupus
    • COI: 1:STN:280:DC%2BC2cnms1Oltw%3D%3D, PID: 24763540
    • Somers EC, Richardson BC. Environmental exposures, epigenetic changes and the risk of lupus. Lupus. 2014;23:568–76.
    • (2014) Lupus. , vol.23 , pp. 568-576
    • Somers, E.C.1    Richardson, B.C.2
  • 59
    • 77954668889 scopus 로고    scopus 로고
    • Mutator transposon activation after UV-B involves chromatin remodeling
    • COI: 1:CAS:528:DC%2BC3cXpslKltrw%3D, PID: 20421734
    • Questa JI, Walbot V, Casati P. Mutator transposon activation after UV-B involves chromatin remodeling. Epigenetics. 2010;5:352–63.
    • (2010) Epigenetics. , vol.5 , pp. 352-363
    • Questa, J.I.1    Walbot, V.2    Casati, P.3
  • 60
    • 84911866508 scopus 로고    scopus 로고
    • The melanoma revolution: from UV carcinogenesis to a new era in therapeutics
    • COI: 1:CAS:528:DC%2BC2cXhvFehurbO, PID: 25414302
    • Lo JA, Fisher DE. The melanoma revolution: from UV carcinogenesis to a new era in therapeutics. Science. 2014;346:945–9.
    • (2014) Science. , vol.346 , pp. 945-949
    • Lo, J.A.1    Fisher, D.E.2
  • 61
    • 84907304074 scopus 로고    scopus 로고
    • The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes
    • PID: 24710217
    • Huether R, Dong L, Chen X, Wu G, Parker M, Wei L, et al. The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. Nat Commun. 2014;5:3630.
    • (2014) Nat Commun. , vol.5 , pp. 3630
    • Huether, R.1    Dong, L.2    Chen, X.3    Wu, G.4    Parker, M.5    Wei, L.6
  • 62
    • 84896536169 scopus 로고    scopus 로고
    • Chromosome 10, frequently lost in human melanoma, encodes multiple tumor-suppressive functions
    • COI: 1:CAS:528:DC%2BC2cXktF2mu70%3D, PID: 24453001
    • Kwong LN, Chin L. Chromosome 10, frequently lost in human melanoma, encodes multiple tumor-suppressive functions. Cancer Res. 2014;74:1814–21.
    • (2014) Cancer Res. , vol.74 , pp. 1814-1821
    • Kwong, L.N.1    Chin, L.2
  • 63
    • 0038456527 scopus 로고    scopus 로고
    • Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer
    • COI: 1:CAS:528:DC%2BD3sXkt12qu7w%3D, PID: 12789284
    • Bastian BC. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer. Oncogene. 2003;22:3081–6.
    • (2003) Oncogene. , vol.22 , pp. 3081-3086
    • Bastian, B.C.1
  • 64
    • 84901437839 scopus 로고    scopus 로고
    • Understanding the biology of melanoma and therapeutic implications
    • PID: 24880940
    • Sullivan RJ, Fisher DE. Understanding the biology of melanoma and therapeutic implications. Hematol Oncol Clin North Am. 2014;28:437–53.
    • (2014) Hematol Oncol Clin North Am. , vol.28 , pp. 437-453
    • Sullivan, R.J.1    Fisher, D.E.2
  • 65
    • 84893835288 scopus 로고    scopus 로고
    • Up close and personal: the challenges of precision medicine in melanoma
    • PID: 24511111
    • Smalley KS, Weber JS. Up close and personal: the challenges of precision medicine in melanoma. J Natl Cancer Inst. 2014;106:djt443.
    • (2014) J Natl Cancer Inst , vol.106 , pp. djt443
    • Smalley, K.S.1    Weber, J.S.2
  • 66
    • 84881483492 scopus 로고    scopus 로고
    • Evolutionary dynamics of cancer in response to targeted combination therapy
    • PID: 23805382
    • Bozic I, Reiter JG, Allen B, Antal T, Chatterjee K, Shah P, et al. Evolutionary dynamics of cancer in response to targeted combination therapy. Elife. 2013;2:e00747.
    • (2013) Elife. , vol.2 , pp. e00747
    • Bozic, I.1    Reiter, J.G.2    Allen, B.3    Antal, T.4    Chatterjee, K.5    Shah, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.